Cochrane Abstracts
Methylxanthine for the prevention and treatment of apnea in preterm infants
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Methylxanthine for the Prevention and Treatment of Apnea in Preterm Infants." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437364/all/Methylxanthine_for_the_prevention_and_treatment_of_apnea_in_preterm_infants.
Methylxanthine for the prevention and treatment of apnea in preterm infants. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437364/all/Methylxanthine_for_the_prevention_and_treatment_of_apnea_in_preterm_infants. Accessed March 21, 2025.
Methylxanthine for the prevention and treatment of apnea in preterm infants. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437364/all/Methylxanthine_for_the_prevention_and_treatment_of_apnea_in_preterm_infants
Methylxanthine for the Prevention and Treatment of Apnea in Preterm Infants [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437364/all/Methylxanthine_for_the_prevention_and_treatment_of_apnea_in_preterm_infants.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methylxanthine for the prevention and treatment of apnea in preterm infants
ID - 437364
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437364/all/Methylxanthine_for_the_prevention_and_treatment_of_apnea_in_preterm_infants
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
